Utility of Next-Generation Sequencing-Based Chimerism Analysis for Early Relapse Prediction following Allogenic Hematopoietic Cell Transplantation
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25052811 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Heerah Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Laboratory Medicine, Chosun University Hospital, Gwangju 61453, Republic of Korea. Hauptthemen laut MEDLINE: Chimerism, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chimerism monitoring following allogeneic hematopoietic cell transplantation (HCT) plays a pivotal role in evaluating engraftment status and identifying early indicators of relapse. Recent advancements in next-generation sequencing (NGS) technology have introduced AlloSeq HCT as a more sensitive alternative to short tandem repeat (STR) analysis. This study aimed to compare AlloSeq HCT with STR, focusing on the prediction of early relapse post-allogeneic HCT. Chimerism levels in 29 HCT recipients were assessed using both STR and NGS, employing a total of 125 whole blood or bone marrow aspirate samples (68 post-HCT and 57 pre-HCT samples from recipients or donors). AlloSeq HCT exhibited high concordance with STR and demonstrated the potential for early detection of chimeric changes, particularly at extremely low levels. The combined advantages of high sensitivity and automated data analysis offered by AlloSeq HCT substantiate its clinical adoption for effective chimerism monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Laboratory Medicine, Chosun University Hospital, Gwangju 61453, Republic of Korea.
- Cancer Research Institute, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
- Department of Laboratory Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
- Department of Genomic Medicine, Seoul National University Hospital, Seoul 03080, Republic of Korea.
ORCID-Profile: Heerah Lee, Moon-Woo Seong
Zitieren
APA
Lee, H., Chae, S. W., Cho, S. I., Lee, J. S., Kim, M. J., & Seong, M. W. (2024). Utility of Next-Generation Sequencing-Based Chimerism Analysis for Early Relapse Prediction following Allogenic Hematopoietic Cell Transplantation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25052811
Vancouver
Lee H, Chae SW, Cho SI, Lee JS, Kim MJ, Seong MW. Utility of Next-Generation Sequencing-Based Chimerism Analysis for Early Relapse Prediction following Allogenic Hematopoietic Cell Transplantation. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25052811
BibTeX
@article{Lee2024,
author = {Lee, Heerah and Chae, Seung-Won and Cho, Sung Im and Lee, Jee-Soo and Kim, Man Jin and Seong, Moon-Woo},
title = {Utility of Next-Generation Sequencing-Based Chimerism Analysis for Early Relapse Prediction following Allogenic Hematopoietic Cell Transplantation},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25052811}
}
EUVIMED